Category: Pharmacotherapy
-
-
-
-
-
-
GAME-CHANGERS IN FOCUS، A Quiz on Landmark Trials of 2024
April 15, 2025Quiz of 2024 landmark Trials
-
-
-
5th Umbrella: Antithrombotic Therapy in Venous Thromboembolism
March 25, 2025Antithrombotic Therapy in VTE
-
5th Umbrella: Antithrombotic Therapy in Atrial Fibrillation
March 25, 2025Antithrombotic Therapy in AF
-
5th Umbrella: Antithrombotic Therapy in Chronic Coronary Syndrome
March 25, 2025Antithrombotic Therapy in CCS
-
5th Umbrella: Antithrombotic Therapy in Acute Coronary Syndrome
March 25, 2025Antithrombotic Therapy in ACS
-
-
-
-
-
-
-
16th AHA 2024 Congress Coverage: ALPACAR-360 Trial
February 1, 202516th AHA 2024: ALPACAR-360 Trial
-
-
-
-
Daily Cardiology 5th Umbrella: The Art of Antithrombotic Therapy In Daily Cardiovascular Practice
January 26, 20255th Umbrella: Antithrombotic Therapy
-
-
-
-
Cardiosignal 83, Antithrombotic therapy Post PCI in CCS patients with an indication for OAC
January 19, 2025Cardiosignal 83
-
-
-
6th AHA 2024 Congress Coverage: Nexiguran Ziclumeran for ATTR Cardiomyopathy
January 19, 20256th AHA 2024: ATTR Cardiomyopathy
-
-
-
-
-
-
Case Discussion 122: Antiarrhythmic and Anticoagulant Therapy After AF Ablation
January 1, 2025Case Discussion 122: Medications after AF Ablation
-
Case Discussion 120: VTE prophylaxis in a CAD patient on ASA, after TKA
December 30, 2024Case Discussion 120: VTE prophylaxis
-
Case Discussion 119: CAC Score Guide in Aspirin and Statin Therapy
December 30, 2024Case Discussion 119: CAC Score
-
1st AHA 2024 Congress Coverage: CLEAR SYNERGY (OASIS 9) Trial, Colchicine
December 25, 20241st AHA 2024: OASIS 9 Trial
-
-
Case Discussion 118: Omalizumab in patient with cardivascular disease
December 22, 2024Case Discussion 118: Omalizumab in CVD
-
Introduction of Hypertension and Hyperlipidemia Academy for non-physician healthcare providers
December 18, 2024Intro of H&H Academy for non-physician healthcare providers
-
2nd Cardiology Online Grand Round: Invasive and Pharmacologic Approach to NSTE-ACS
December 17, 2024Online Grand Round: Approach to NSTE-ACS
-
Hypertension and Hyperlipidemia Academy for non-physician healthcare providers
December 2, 2024H&H Academy for non-physician healthcare providers
-
-
Cardiosignal 81, changing Enalapril to an ARNI in a HErEF Patient with ESRD
November 23, 2024Cardiosignal 81
-
Save The Date: 2nd Cardiology Online Grand Round
November 19, 2024Save The Date: 2nd Cardiology Online Grand Round
-
Cardiosignal 79, Antithrombotic therapy post PCI in CCS patients with an indication for OAC
November 10, 2024Cardiosignal 79
-
-
-
-
-
-
-
-
-
34th ESC 2024 Congress Coverage: De-escalation to ticagrelor monotherapy vs. 12 months of dual antiplatelet therapy
October 16, 202434th ESC 2024: Ticagrelor monotherapy vs. dual antiplatelet therapy
-
31st ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (3)
October 13, 202431st ESC 2024: ESC 2024 CCS Guideline (3)
-
30th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (2)
October 12, 202430th ESC 2024: ESC 2024 CCS Guideline (2)
-
28th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (1)
October 12, 202428th ESC 2024: ESC 2024 CCS Guideline (1)
-
26th ESC 2024 Congress Coverage: Lowering of non–high-density lipoprotein cholesterol after Myocardial Infarction
October 9, 202426th ESC 2024: ILowering of non-HDL cholesterol after MI and prognosis
-
-
-
-
20th ESC 2024 Congress Coverage: OCEANIC-AF Trial
September 30, 202420th ESC 2024: OCEANIC-AF Trial
-
19th ESC 2024 Congress Coverage: Stop-or-Not Trial
September 30, 202419th ESC 2024: Stop-or-Not Trial
-
17th ESC 2024 Congress Coverage: Sudden Cardiac Death
September 30, 2024Among Persons with Diabetes Aged 1–49 years
-
-
-
9th ESC 2024 Congress Coverage: BedMed and BedMed-Frail Trials
September 18, 20249th ESC 2024: BedMed and BedMed-Frail Trials
-
-
6th ESC 2024 Congress Coverage: Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
September 18, 20246th ESC 2024: Vutrisiran
-
-
-
-
-
-
-
-
Daily Cardiology Symposium 1403: Antithrombotics in Preventive Cardiology
July 17, 2024DCS 1403: Antithrombotics
-
-
-
-
-
-
Case Discussion 117 Answer: VTE prophylaxis in acutely ill hospitalized medical patients
June 19, 2024Case Discussion 117 Answer: VTE prophylaxis in hospitalized patients
-
-
-
-
-
-
ACC.24 Congress Coverage: Superiority Trial of Enalapril to Prevent Anthracycline-induced Cardiotoxicity
May 7, 2024ACC.24: PROACT Trial
-
Save The Date: Hypertension and Hyperlipidemia Academy, No. 16
May 7, 2024Save The Date: 15th H&H Academy
-
ACC.24 Congress Coverage: Empagliflozin after Acute Myocardial Infarction
May 5, 2024ACC.24: EMPACT-AMI trial
-
ACC.24 Congress Coverage: Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care
April 30, 2024ACC.24: KARDIA-2 trial
-
ACC.24 Congress Coverage: Safety and Efficacy of Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy
April 27, 2024ACC.24: IMPROVE-HCM trial
-
ACC.24 Congress Coverage: Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl
April 27, 2024ACC.24: REDUCE-IT trial
-
ACC.24 Congress Coverage: An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
April 27, 2024ACC.24: VICTORION-INITIATE trial
-
ACC.24 Congress Coverage: A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication
April 22, 2024ACC.24: TACTiC Trial
-
ACC.24 Congress Coverage: Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
April 17, 2024Infarction ACC.24: AEGIS-II Trial
-
ACC.24 Congress Coverage: Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
April 17, 2024ACC.24: ARISE-HF Trial
-
ACC.24 Congress Coverage: Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease
April 17, 2024ACC.24: SGLT2i in ACHD
-
ACC.24 Congress Coverage: Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
April 17, 2024ACC.24: Bridge TIMI 73a Trial
-
ACC.24 Congress Coverage: The Trial to Assess Chelation Therapy 2
April 16, 2024ACC.24: TACT 2 Trial
-
ACC.24 Congress Coverage: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
April 16, 2024ACC.24: Semaglutide in HFpEF and DM
-
-
-
Case Discussion 115 Answer: Hormonal Contraceptive Medications in Patients with Hypertension
April 6, 2024Case Discussion 115 Answer: OCPs in Hypertensive patients
-
Case Discussion 111 Answer: Perioperative Management of Antiplatelet Medications in CCS Patients Undergoing CABG
April 6, 2024Case Discussion 111 Answer: Antiplatelet therapy before CABG in CCS patients
-
Impact: Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors
April 6, 2024Impact: Nitrates and PDE-5 inhibitors and Nitrates in CAD
-
Impact: Why Do GLP-1 Drugs Stop Working, and What to Do About It?
April 6, 2024Impact: GLP-1 agonists in the treatment of obesity
-
Cardiology Online Grand Round: The Art of Optimal Medical Therapy for Heart Failure
April 1, 2024Cardiology Online Grand Round: OMT in HF
-
Case Discussion 114 Answer: Cardiovascular considerations in patients receiving FLOT chemotherapy regimen
March 16, 2024Case Discussion 112 Answer: FLOT chemotherapy regimen and cardiovascular system
-
Light Rounds Volume 7: Elderly gentleman with HTN, ICMP and SCAF
March 16, 2024Light Round Volume 7: Approach to a patient with subclinical AF
-
Save The Date: Cardiology Online Grand Round
March 6, 2024Save The Date: Cardiology Online Grand Round
-
-
mpact: Cardiovascular and Non-cardiovascular Prescribing and Mortality After Takotsubo – Comparison With Myocardial Infarction and General Population
February 3, 2024Impact: Mortality After Takotsubo – Comparison With MI and General Population
-
Case Discussion 113 Answer: Considerations before initiating antihypertensive treatment
January 30, 2024Case Discussion 113 Answer: Choosing the best antihypertensive agent
-
Impact: Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism
January 20, 2024mpact: High Risk PE
-
Impact: Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
January 20, 2024Impact: SAPT 1 year after PCI
-
Case Discussion 110 Answer: Tapering off and discontinuing medical therapy in acute idiopathic pericarditis
January 19, 2024Case Discussion 110 Answer: Medical therapy in acute pericarditis
-
Case Discussion 109 Answer: GI protection in patients on single antiplatelet therapy
January 16, 2024Case Discussion 109 Answer: GI protection in SAPT
-
-
-
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Pros by Dr. Hadaegh
January 6, 2024Diabeat 9th session, case based discussion
-
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Cons by Dr. Ghanavati
January 6, 2024Diabeat 9th session, case based discussion
-
-
Diabeat: the 9th diabetes masterclass for cardiologists, case-based discussion
December 30, 2023Diabeat 9th session, case based discussion
-
-
-
-
Case Discussion 98 Answer: Long term anticoagulation after cerebral venous sinus thrombosis
November 27, 2023Case Discussion 98 Answer: Anticoagulation after cerebral venous sinus thrombosis
-
AHA23 Congress Coverage: Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial
November 20, 2023A23 Congress Coverage: Lepodisiran Dose-Ascending Trial
-
AHA23 Congress Coverage: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation: ARTESIA trial
November 18, 2023AHA23 Congress Coverage: Apixaban in subclinical AF (ARTESIA)
-
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure: DAPA-MI trial
November 18, 2023AHA23 Congress Coverage: Dapagliflozin in MI without DM or HF (DAPA MI)
-
AHA23 Congress Coverage: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes: SELECT trial
November 18, 2023AHA23 Congress Coverage: Semaglutide in obesity and no DM (SELECT trial)
-
AHA23 Congress Coverage: Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia: MINT trial
November 15, 2023AHA23 Congress Coverage: Blood Transfusion in MI and Anemia (MINT trial)
-
AHA23 Congress Coverage: Hypertension Treatment and Risk of Dementia
November 14, 2023AHA23 Congress Coverage: HTN and Dementia
-
Case Discussion 106: Approach to the diagnosis and management of asymptomatic hyperuricemia
November 13, 2023Case Discussion 102: asymptomatic hyperuricemia
-
-
-
Light Rounds Volume 6: Elderly gentleman with T2D, CAD and foot ulcer
October 15, 2023Light Round Volume 6: Approach to a patient with an ischemic foot ulcer
-
Light Rounds Volume 5: 22 Y/O lady with frequent PVCs
October 11, 2023Light Round Volume 5: Approach to a patient with frequent PVCs
-
Case Discussion 99: Choosing P2Y12 inhibitors in STEMI patients treated with Fibrinolytics and undergoing PCI
October 2, 2023Case Discussion 99: P2Y12 choice for PCI after fibrinolytic Tx
-
Impact: When Does a Calcium Score Equate to Secondary Prevention?
September 30, 2023Impact: New Evidence for Interpreting Calcium Score
-
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiomyopathies
September 17, 2023ESC 2023: New Cardiomyopathies Guideline
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
September 17, 2023ESC 2023: New DM and CVD Guideline
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of endocarditis
September 11, 2023ESC 2023: New Endocarditis Guideline
-
-
ESC 2023 Congress Coverage: 2023 Focused Update of the 2021 HF Guideline
September 9, 2023ESC 2023: HF Guideline Update
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Lost Puzzle In Diabetes Treatment: CAD and PAD in Patients with Diabetes
August 21, 2023CAD and PAD in DM
-
-
Impact: Clinical Outcomes of Calcium Channel Blockers versus Beta Blockers after Acute MI
August 20, 2023Impact: CCBs VS BBs post AMI
-
-
-
Impact: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
August 14, 2023Impact: Zilebesiran
-
-
Impact: Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
August 12, 2023Impact: Anticoagulation in AF and stroke
-
-
-
Impact: Combination lipid-lowering therapy after PCI
August 1, 2023Impact: Dyslipidemia treatment after PCI
-
Daily Cardiology Symposium 1402 Day 2 Panel 4
July 25, 2023Infective Endocarditis and Prosthetic Valve Malfunction
-
Daily Cardiology Symposium 1402 Day 2 Panel 3
July 25, 2023Chronic Limb-Threatening Ischemia and Acute Aortic Syndromes
-
-
Daily Cardiology Symposium 1402 Day 2 Panel 1
July 25, 2023Acute Pericarditis and Cardiac Tamponade
-
Daily Cardiology Symposium 1402 Day 1 Panel 4
July 25, 2023Hypertension Crisis and Acute Hypertension in Pregnancy
-
Daily Cardiology Symposium 1402 Day 1 Panel 3
July 25, 2023Acute Coronary Syndrome and Acute Chest Pain
-
Daily Cardiology Symposium 1402 Day 1 Panel 2
July 25, 2023Acute De Novo Heart Failure and Cardiogenic Shock
-
Daily Cardiology Symposium 1402 Day 1 Panel 1
July 25, 2023Cardiopulmonary resuscitation and Narrow-complex Tachyarrhythmia
-
-
-
NEJM Knowledge plus Case Discussion
July 24, 2023a Case Discussion from NEJM Knowledge plus service
-
-
-
-
-
-
-
Vision: Adults with fasting TG=150-500mg with ASCVD or DM
July 3, 2023Vision: Mild hypertriglyceridemia in moderate to high risk patients
-
-
-
-
-
-
Cardiac considerations and monitoring in patients receiving Acetylcholinesterase inhibitors
June 12, 2023Acetylcholinesterase inhibitors' cardiac considerations
-
-
-
Light Rounds Volume 3: elderly gentleman with ICMP and LV thrombus
June 6, 2023Light Rounds 3: LV thrombus
-
-
-
-
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physician healthcare professionals
May 18, 2023H&H Academy: clinical tips for non-physicians
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Aminian
May 18, 2023YCA 1402 introduction by Dr. Aminian
-
-
-
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Shishehbor
May 13, 2023YCA 1402 introduction by Dr. Shishehbor
-
-
-
Impact: Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure
May 6, 2023Impact: Sacubitril/Valsartan and renal function in HF
-
-
Save the Date: American College of Cardiology 2023 Congress Coverage
May 1, 2023Save the Date: ACC.23 congress coverage
-
-
Young Cardiologist Award 1402 Introduction video by A. Yahyavi, MD
April 29, 2023YCA 1402 introduction by Dr. Yahyavi
-
-
-
Vision: Adults with fasting TG=150-500mg without ACVD or DM
April 15, 2023Vision: Mild hypertriglyceridemia in low-risk patients
-
Daily Cardiology Symposium 1402 Save The Date poster Motion
April 10, 2023DCS 1402 Save The Date Poster Motion
-
-
-
-
-
-
Hypertension and Hyperlipidemia Academy: Smoothing the path to cardiovascular risk reduction
February 15, 2023H&H Academy: CVD risk reduction
-
-
Case Discussion 70: Potassium supplementation in mild to moderate Hypokalemia
January 21, 2023Case Discussion 70: Management of mild to moderate Hypokalemia
-
-
Impact: Management of ACS in older adults, an AHA statement
December 24, 2022Impact: ACS in the elderly
-
Case Discussion No. 68 Answer: anticoagulation in pregnancy
December 19, 2022Case Discussion No. 68 Answer
-
-
-
Impact: Dual antiplatelet therapy with Ticagrelor and graft failure after coronary artery bypass grafting
November 2, 2022Dual antiplatelet Tx. with Ticagrelor and graft failure after CABG
-
Impact: Acetaminophen in comparison to NSAIDs in cardiovascular diseases
October 31, 2022Impact: Acetaminophen vs. NSAIDs in CVD
-
Impact: Association of Sacubitril/Valsartan administration and the severity of functional MR in HFrEF
October 16, 2022Impact: Sacubitril/Valsartan and MR severity in HFrEF
-
Impact: Effect of statin therapy on muscle symptoms
September 26, 2022Impact: Effect of statin therapy on muscle symptoms
-
-
-
-
Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair
September 18, 2022Vision, 3rd episode: antithrombotic Tx. in bioprosthetic valves and valve repair
-
-
Save the date: Cardiorenal Metabolic Crossroads, 5th session
September 13, 2022Save the date: Cardiorenal Metabolic Crossroads, 5th session
-
Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40%
September 13, 2022Umbrella: HF, Heart Failure with EF>40%
-
Umbrella: Heart Failure, Panel 3, Acute Decompensated Heart Failure
September 13, 2022Umbrella: HF, Acute Decompensated HF
-
Umbrella: Heart Failure, Panel 1, Pharmacotherapy in HFrEF
September 13, 2022Umbrella: HF, Pharmacotherapy in HFrEF
-
Care Gaps in Adherence to Heart Failure Guidelines
September 12, 2022Care Gaps in Adherence to Heart Failure Guidelines
-
-
-
-
-
Save the date: Case-based discussion in patients with diabetes
August 30, 2022Save the date: Case-based discussion in patients with diabetes
-
-
-
-
-
-
-
-
-
-
-
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
-
Save the date: Hypertension and Hyperlipidemia Academy No. 10
August 18, 2022Save the date: H&H Academy No. 10
-
-
-
-
-
Cardio-Signal 51
August 5, 2022Management of antithrombotic therapy after prosthetic valve implantation
-
-
-
-
-
-
-
-
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare profesionals
July 19, 2022H&H Academy 10, for non-physician healthcare professionals
-
-
-
-
-
-
Save the date: Hypertension and Hyperlipidemia Academy, No. 9
June 28, 2022Save the date: The 9th H&H Academy
-
Daily Cardiology Symposium 1401, Day 2 Panel 4: Valvular heart disease
June 26, 2022DCS 1401: Valvular heart disease
-
-
-
-
-
Daily Cardiology Symposium 1401, Day 1 Panel 4: Peripheral vascular diseases
June 26, 2022DCS 1401: Peripheral vascular diseases
-
Daily Cardiology Symposium 1401, Day 1 Panel 3: Venous thromboembolism (VTE) prophylaxis
June 26, 2022DCS 1401: Venous thromboembolism (VTE) prophylaxis
-
Daily Cardiology Symposium 1401, Day 1 Panel 2: Revascularization in CAD
June 26, 2022DCS 1401: Revascularization in CAD
-
Daily Cardiology Symposium 1401, Day 1 Panel 1: Pharmacotherapy in CAD
June 26, 2022DCS 1401: Pharmacotherapy in CAD
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
Save the date: Hypertension and Hyperlipidemia Academy, 8th
May 10, 2022Save the date: 8th H&H Academy
-
-
American College of Cardiology (ACC) congress 2022 landmark trials review
May 3, 2022ACC 2022 congress coverage
-
-
At a glance: Ticagrelor and prevention of recurrent thrombotic events in CCS
April 23, 2022Ticagrelor and secondary prevention in CCS
-
-
Daily Cardiology Symposium 1401 faculty and executive committee
April 18, 2022DCS 1401 faculty and executive committee
-
-
-
-
-
-
-
-
-
Familial hypercholesterolemia, a narrative review, part 2: diagnosis and screening
March 11, 2022FH 1: diagnosis and screening
-
-
-
-
-
-
Umbrella: Hypertension, Challenges in the diagnosis & management of HTN
March 8, 2022Umbrella: HTN, diagnosis and management of HTN
-
Save the date: Hypertension and Hyperlipidemia Academy 7
March 3, 2022Save the date: the 7th H&H Academy session
-
Save the date: Cardiometabolic grand round 6
March 2, 2022Save the date: the 6th cardiometabolic grand round
-
HeartCast 5: practical approach to the treatment of HFrEF
February 23, 2022The fifth HeartCast: HFrEF management
-
-
-
-
-
HeartCast 4: practical approach to the treatment of HFrEF
February 9, 2022The fourth HeartCast: HFrEF management
-
-
-
-
-
-
which prophylaxis? for whom? VTE prophylaxis panel discussion
January 26, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: which prophylaxis? for whom? VTE prophylaxis panel discussion
January 19, 2022Case-based panel discussion on VTE prophylaxis
-
Hypertension and Hyperlipidemia Academy: for nurses and medical assistants
January 18, 2022H&H Academy: nurses and assistants
-
Familial hypercholesterolemia, a narrative review, part 1: definition and burden
January 14, 2022FH 1: Definition and burden
-
HeartCast 3: practical approach to the treatment of HFrEF
January 11, 2022The third HeartCast: HFrEF management
-
Hypertension and Hyperlipidemia Academy 5, a hybrid event
January 7, 20225th session of H&H Academy, online and onsite
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
At a Glance: Approach to Ticagrelor-induced Dyspnea
January 2, 2022Managing dyspnea induced by Ticagrelor
-
Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke
January 2, 2022Umbrella H&S: session 4, secondary prevention of stroke
-
Umbrella Heart and Stroke: session 3, Atrial fibrillation screening
January 2, 2022Umbrella H&S: session 3, AF screening
-
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
January 2, 2022Umbrella H&S: session 2, carotid stenosis
-
Umbrella Heart and Stroke: session 1, detecting & managing patients with PFO
January 2, 2022Umbrella H&S: session1, PFO
-
HeartCast 2: practical approach to the treatment of HFrEF
December 29, 2021The second HeartCast: HFrEF management
-
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
December 29, 2021Rivaroxaban vs Apixaban in AF
-
-
-
-
At a glance: preventing cardiovascular thrombotic event after ACS
December 21, 2021Ticagrelor in preventing post-ACS thrombotic events
-
HeartCast 1: practical approach to the treatment of HFrEF
December 15, 2021The first HeartCast: HFrEF management
-
-
-
-
Ticagrelor Hub: when to use and which dose?
November 28, 2021The dosage and indications of Ticagrelor
-
Cardiometabolic Grand round, Session 5
November 21, 2021The 5th session of Cardiometabolic grand round
-
Save the date: Hypertension and hyperlipidemia academy, session 4
November 16, 2021The 4th session of Hypertension and hyperlipidemia academy
-
Save the date: Umbrella: Heart and Stroke
November 14, 2021The second program of Umbrella series: Heart and Stroke
-
Save the date: Cardiometabolic grand round, 5th session
November 8, 2021The 5th session of Cardiometabolic grand round program
-
Primary prevention in dyslipidemia as the only cardiovascular risk factor
November 4, 2021Dyslipidemia in primary prevention of low-risk patients
-
Late-breaking Science in Cardiovascular disease prevention
November 2, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session
November 1, 2021The 4th session of Cardiorenal metabolic crossroads program
-
Management of dyslipidemia in diabetic patients
October 24, 2021DLP and T2DM: approach and management
-
DiaBeat: The Beating Heart of Diabetes (8th session)
October 19, 20218th Diabetes Masterclass for Cardiologists
-
-
Save the date: Late-breaking Science in Cardiovascular disease prevention
October 19, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
Save the date; DiaBeat: The Beating Heart of Diabetes
October 9, 20218th Diabetes Masterclass for Cardiologists
-
-
Cardiopoint 13: Management of stage 1 hypertension in adults with low cardiovascular risk
September 25, 2021Stage 1 HTN in low risk patients
-
-
-
-
Cardio-Watch Podcast: Episode 7, ESC 2021 special
September 20, 2021The seventh episode of Cardio-Watch: ESC 2021
-
-
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
September 17, 2021The role of Heparin in the management of thrombosis in COVID-19
-
-
-
-
-
-
-
-
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
August 24, 2021Neprilysin Inhibitors to prevent LV remodeling post MI
-
The clinical landscape for Diabetes and Cardiovascular disease
August 24, 2021T2DM and cardiovascular diseases: The clinical landscape
-
-
-
Midodrine for the prevention of vasovagal syndrome: a randomized clinical trial
August 22, 2021Midodrine in vasovagal syndrome prevention
-
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
August 21, 2021Impact of Dapagliflozin on the survival of HFrEF patients
-
Milrinone compared with Dobutamine in cardiogenic shock: DOREMI trial
August 15, 2021Milrinone vs. Dobutamine: DOREMI trial
-
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
August 14, 20217th Diabetes Masterclass for Cardiologists
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
August 14, 2021Antithrombotic regimens in CAD
-
Symptom matters: angina control in coronary artery disease
August 14, 2021From surrogates to symptom control in CAD
-
-
-
-
Save the date: The first Umbrella event: chronic coronary syndrome
August 8, 2021First Umbrella session: CCS
-
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
August 4, 2021Preventing thromboembolic events in COVID-19
-
-
Save the date: Anti-thrombotic lighthouse: navigating a new path to CAD management
August 2, 2021Anti-thrombotic lighthouse, 3rd session: anti-thrombotic therapy in CAD Cardio Calendar
-
-
Save the date: Diabeat: 7th session, SGLT2 Inhibitors for Primary Prevention of CVD
August 1, 20217th diabeat masterclass for cardiologists: SGLT2i in CVD primary prevention
-
-
Save the date: Finding the optimal thromboprophylaxis regimen in patients with COVID-19
July 31, 2021thromboprophylaxis in COVID-19
-
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
-
-
-
Save the date: Anti-Thrombotic Lighthouse (2nd session)
July 14, 20212nd session of Anti-Thrombotic Lighthouse: antiplatelet therapy in CCS
-
-
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
July 12, 2021The fifth episode of Cardio-Watch: cardiometabolic disorders
-
Marking the antiplatelet therapy maze in ACS
July 12, 2021How to prevent atherosclerotic cardiovascular events
-
Safety and Efficacy of different antithrombotic strategies after TAVI
July 11, 2021Post-TAVI antithrombotic strategies
-
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
July 5, 2021Diagnosis and management of Iron deficiency in HF patients
-
-
-
Cardio-Watch Podcast: Episode 4, Dyslipidemia
June 28, 2021The fourth episode of Cardio-Watch: Dyslipidemia
-
Save the date: Anti-Thrombotic Lighthouse (1st session)
June 26, 20211st session of Anti-Thrombotic Lighthouse: antiplatelet therapy in ACS
-
DiaBeat: The Beating Heart of Diabetes (6th session)
June 24, 20216th Diabetes Masterclass for Cardiologists
-
Cardiometabolic Grand Round: 4th session
June 24, 2021Guideline-directed cardiovascular evaluations before surgery
-
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
June 20, 2021SGLT2Is and the prevention of cardiovascular complications in T2DM
-
DCS 1400: session 8, Valvular Heart disease
June 16, 2021The eighth panel of DCS 1400: Valvular Heart disease
-
-
-
-
-
-
DCS 1400: session 2, Diabetes for cardiologists
June 16, 2021The second panel of DCS 1400: diabetes for cardiologists
-
-
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
June 13, 2021The Third episode of Cardio-Watch: AF
-
Save the date; DiaBeat: The Beating Heart of Diabetes
June 8, 20216th Diabetes Masterclass for Cardiologists
-
A review on four landmark anti-platelet therapy trials
June 1, 2021The latest updates on anti-platelet therapy from 4 important trials
-
Save the date: Cardiometabolic Grand Round 4th session
June 1, 2021The fourth session of Cardiometabolic grand round
-
Cardiopoint 12: Two-Drug Combinations as First-Step Antihypertensive treatment
May 30, 2021Initial administration of two-drug combinations in HTN
-
Cardio-Watch podcast: Episode 2, Hypertension
May 29, 2021The second episode of Cardio-Watch: Hypertension
-
Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI
May 20, 2021The comparison of Clopidogrel and Aspirin monotherapy after PCI (HOST-EXAM trial)
-
How to reduce the atherosclerotic cardiovascular risk
May 18, 2021A case-based Review on HTN and DLP management
-
Updates on the management of Diabetes and cardiometabolic disease
May 18, 2021Actoverco Diabetes Lunch Webinar
-
Impact: DAPT vs. Aspirin in patients with stroke or TIA
May 16, 2021A recent meta-analysis about antiplatelet therapy in stroke
-
The evolution of antiplatelet therapy in CAD: a 45 year journey
May 10, 2021A brief history of anti-platelet therapy in CAD
-
-
DiaBeat: The Beating Heart of Diabetes (5th session)
May 1, 20215th Diabetes Masterclass for Cardiologists
-
-
Save the date: Abidi Hypertension and Hyperlipidemia Academy
April 19, 2021Keeping up-to-date on HTN and DLP treatment
-
Impact: No-LVT trial
April 13, 2021Comparative study of oral anticoagulation in left ventricular thrombi
-
DiaBeat: The Beating Heart of Diabetes (4th session)
April 12, 20214th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (3rd session)
April 12, 20213rd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (2nd session)
April 11, 20212nd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (1st session)
April 10, 20211st Diabetes Masterclass for Cardiologists
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
April 7, 2021Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline
April 6, 2021Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
-
-
-
PCSK9 inhibitors place in patients with cardiometabolic diseases
March 16, 2021PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist
-
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
March 11, 2021Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Save the date; DiaBeat: The Beating Heart of Diabetes
February 23, 20214th Diabetes Masterclass for Cardiologists
-
Guideline Directed Medical Therapy in Patients with HF
February 17, 2021Quick review on place of MRAs in patients with HFrEF
-
Guideline Directed Medical Therapy in Patients with HF
February 7, 2021Quick review on place of Beta-Blockers in patients with HFrEF
-
CardioPoint (10): The growing burden of cardiovascular diseases
February 2, 2021Emphasizing the importance of CVD prevention and management
-
Guideline Directed Medical Therapy in Patients with HF
February 1, 2021Updates on ACEI/ARB place in patients with HFrEF (2021 Guideline)
-
Save the date; DiaBeat: The Beating Heart of Diabetes
January 28, 20213rd Diabetes Masterclass for Cardiologists
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
-
Forth Case: Extreme Body Weights
January 21, 2021OAC choice in patients with obesity or low body weights, any role for DOACs?
-
Third Case: AF & Artificial Heart Valves
January 21, 2021OAC of choice in patients with artificial heart valves
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
First Case: Elective PCI and AF
January 21, 2021Antithrombotic regimen of choice in patients with AF undergoing elective PCI
-
Impact: Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomized, open-label trial
January 20, 2021Continue vs Stop of RAS inhibitors in patients with COVID-19
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Residents’ Island: Abidi CVD Prevention Academy
January 12, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: Residents’ Island; Abidi CVD Prevention Academy
January 1, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: SGLT2 inhibition: Making waves in the heart failure landscape
December 31, 2020Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Save the date: Cardiometabolic Grand Round (2)
December 27, 2020A brief talk on DM medication challenges in patients with CVD
-
Impact: EMPA-RESPONSE-AHF
December 7, 2020Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)
-
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
December 7, 2020Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
-
Cardiometabolic Grand Round (2)
December 7, 2020A brief talk on DM medication challenges in patients with CVD
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
December 3, 2020Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
-
A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)
December 2, 2020A quick review on the findings of TIPS-3 trial from AHA congress 2020
-
The role of Omega 3 and Vitamin D in the Primary Prevention of AF (VITAL-RHYTHM Trial)
December 2, 2020Dietary Supplements and AF
-
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
December 2, 2020The Important findings of SCORED trial from AHA 2020 congress in brief
-
High Dose Vs Standard Dose Influenza Vaccine in Patients with a High-Risk for Cardiovascular Disease (INVESTED)
December 2, 2020A quick review on the findings of INVESTED trial from AHA congress 2020
-
Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in HF (GALACTIC-HF Trial)
December 2, 2020A quick review on the findings of GALACTIC-HF trial from AHA congress 2020
-
Rilonacept (IL-1α and β inhibitor) in the treatment of recurrent pericarditis
November 30, 2020a pivotal symptomatology and outcomes study (RHAPSODY Trial)
-
Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor+ASA for Prevention of Stroke and Death (THALES Trial)
November 30, 2020The effects of Ticarelor+ASA in Acute Stroke
-
Effects of Evolocumab on Complex Coronary Disease Requiring Revascularization
November 30, 2020Evolocumab in the pipeline
-
Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)
November 30, 2020Sotagliflozin in T2DM and exacerbated HF
-
-
-
Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)
November 26, 2020Iron supplementation in acute heart failure
-
Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve
November 26, 2020The findings of RIVER trial
-
Cryoablation or Drug Therapy for the Initial Treatment of AF (EARLY-AF)
November 26, 2020Treatment strategies of AF
-
New FDA approved indication for Ticagrelor
November 6, 2020Ticagrelor approved for recurrent stroke prevention
-
Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes
November 4, 2020Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD
-
Treatment goals for LDL cholesterol across categories of total CV risk
November 4, 2020Overview of 2019 ESC/EAS Guidelines for the management of dyslipidemia
-
Finerenone Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD Trial)
November 3, 2020Finerenone protecting kidneys
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
November 3, 2020Part Two: Prevention of thromboembolic events Patients with AF and an ACS, PCI or CCS
-
Save the date: Cardiometabolic Grand Round
November 1, 2020A brief talk on DM management in patients with CVD
-
-
Monitor eGFR in Patients Treated with Metformin
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Glycemic Management for patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Save the date: ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 31, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Save the date: Comprehensive risk reduction in DM
October 29, 2020Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work
-
Save the date: Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism
October 29, 2020Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism
October 29, 2020Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field
-
Save the Date: What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
Save the date: Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial
October 20, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial
October 20, 2020Monthly Case-Based Clinical Problem Solving
-
Save the date: VTE Prophylaxis in Patients with COVID-19
October 20, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
VTE Prophylaxis in Patients with COVID-19
October 19, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
At a glance; Place of FDC in CV outcomes
October 7, 2020Single-Pill Combination Therapy and CV Outcomes in HTN
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
October 3, 2020Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)
-
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 2, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Diabetes and Cardiovascular Diseases
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
-
Ground-breaking research from ESC Congress 2020 (23)
September 16, 2020Part Twenty-three: Trial Review, ELDERCARE-AF
-
Ground-breaking research from ESC Congress 2020 (22)
September 16, 2020Part Twenty-Two: Trial Review, ATPCI
-
Ground-breaking research from ESC Congress 2020 (21)
September 16, 2020Part Twenty-One: Trial Review, BPLTTC (CANCER)
-
Ground-breaking research from ESC Congress 2020 (20)
September 16, 2020Part Twenty: Trial Review, POPULAR TAVI
-
Ground-breaking research from ESC Congress 2020 (19)
September 16, 2020Part Nineteen: Trial Review, EXPLORER-HCM
-
Ground-breaking research from ESC Congress 2020 (17)
September 16, 2020Part Seventeen: Trial Review, REALITY
-
Ground-breaking research from ESC Congress 2020 (16)
September 16, 2020Part Sixteen: Trial Review, BPLTTC
-
Ground-breaking research from ESC Congress 2020 (15)
September 16, 2020Part Fifteen: Trial Review, PARALLAX
-
Ground-breaking research from ESC Congress 2020 (14)
September 16, 2020Part Fourteen: Trial Review, POPULAR CABG
-
Ground-breaking research from ESC Congress 2020 (12)
September 16, 2020Part Twelve: Trial Review, EVAPORATE
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (9)
September 16, 2020Part Nine: Trial Review, RATE-AF
-
Ground-breaking research from ESC Congress 2020 (8)
September 16, 2020Part Eight: Trial Review, COPS
-
Ground-breaking research from ESC Congress 2020 (7)
September 16, 2020Part Seven: Trial Review, COLCOT
-
Ground-breaking research from ESC Congress 2020 (6)
September 16, 2020Part Six: Trial Review, LoDoCo2
-
Ground-breaking research from ESC Congress 2020 (5)
September 16, 2020Part Five: Trial Review, EAST-AFNET4
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
Ground-breaking research from ESC Congress 2020 (3)
September 16, 2020Part Three: Trial Review; THEMIS, PAD
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Case Discussion (30)
September 12, 2020Optimal Antithrombotic Regimen Early & Late After Discharge in Patients Presenting With STEMI
-
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
-
-
Impact: Efficacy and safety of Trimetazidine after PCI
September 1, 2020The findings of ATPCI trial
-
Impact: adding Ticagrelor to Aspirin in CABG patients
September 1, 2020The findings of POPular CABG trial
-
Impact: Colchicine in patients with acute coronary syndrome
September 1, 2020The findings of COPS trial
-
Impact: Colchicine in patients with chronic coronary syndrome
September 1, 2020The findings of LoDoCo2 trial
-
Impact: Mavacamten for the treatment of symptomatic HCM
August 31, 2020The findings of EXPLORER HCM trial
-
Impact: Aspirin with or without Clopidogrel after TAVI
August 31, 2020The findings of POPULAR TAVI trial
-
Impact: cardiovascular and renal outcomes of Empagliflozin in HF
August 31, 2020The findings of EMPEROR-REDUCED trial
-
-
Impact: Intracoronary infusion of bone marrow-derived mononuclear cells in AMI
August 31, 2020The findings of BAMI trial
-
Impact: Time-to-treatment of Colchicine and post-MI cardiovascular outcomes
August 31, 2020The findings of COLCOT trial
-
Daily Cardiology Journal Club: Second Session – ISCHEMIA Trial
August 27, 2020Monthly Case-Based Clinical Problem Solving
-
CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations
August 22, 2020A Brief Description on Practical Points in Anticoagulation
-
Save the date: Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Save the date: Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease